Discontinuation of Infliximab Therapy in Patients with Crohn's Disease | NEJM Evidence
Alimentary Pharmacology & Therapeutics | Pharmacology Journal | Wiley Online Library
Histologic Remission: The Ultimate Therapeutic Goal in Ulcerative Colitis? - ScienceDirect
Therapeutic guidelines on ulcerative colitis: A GRADE methodology based effort of GETECCU | Gastroenterología y Hepatología
![available as Supplementary data at ECCO-JCC online]. | Download Table](https://www.researchgate.net/publication/289686991/figure/tbl1/AS:667881423507459@1536246748177/available-as-Supplementary-data-at-ECCO-JCC-online.png "available as Supplementary data at ECCO-JCC online]. | Download Table")
available as Supplementary data at ECCO-JCC online]. | Download Table
Probiotic supplementation induces remission and changes in the immunoglobulins and inflammatory response in active ulcerative colitis patients: A pilot, randomized, double-blind, placebo-controlled study - Clinical Nutrition ESPEN
Histologic healing and factors associated with complete remission following conventional treatment in ulcerative colitis - Øyvind Steinsbø, Arne Carlsen, Ole Gunnar Aasprong, Lars Aabakken, Espen Tvedt-Gundersen, Steinar Bjørkhaug, Rune Gjerde, Lars ...
Frontiers | Monitoring of patients with active inflammatory bowel disease
Alimentary Pharmacology & Therapeutics | Pharmacology Journal | Wiley Online Library
Definition of remission of ra | PPT
Full article: Long-term deep remission during maintenance therapy with biological agents in inflammatory bowel diseases
Systematic review and meta-analysis: real-world data rates of deep remission with anti-TNFα in inflammatory bowel disease | BMC Gastroenterology | Full Text
Efficacy Data | SKYRIZI® (risankizumab-rzaa)
Evidence-based clinical practice guidelines for inflammatory bowel disease 2020 | Journal of Gastroenterology
Serum biomarkers confirming stable remission in inflammatory bowel disease | Scientific Reports
De-escalation of immunomodulator and biological therapy in inflammatory bowel disease - The Lancet Gastroenterology & Hepatology
Frontiers | Inflammatory Indexes for Assessing the Severity and Disease Progression of Ulcerative Colitis: A Single-Center Retrospective Study
Artificial Intelligence Enabled Histological Prediction of Remission or Activity and Clinical Outcomes in Ulcerative Colitis - Gastroenterology
Exploring the concept of deep remission in Crohn's disease: correlation between transmural healing and biomarkers - Fabiana Castiglione, Nicola Imperatore, Anna Testa, Roberto de Sire, Olga Maria Nardone, Simona Ricciolino, Imma Di
Efficacy - RINVOQ® (upadacitinib) for Ulcerative Colitis
Remission endpoints in ulcerative colitis: A systematic review
Ulcerative Colitis (UC): Efficacy | STELARA® (ustekinumab) HCP
The long-term effect of biologics in patients with ulcerative colitis emerging from a large Japanese cohort | Scientific Reports
JCM | Free Full-Text | The Management of Postoperative Recurrence in Crohn’s Disease
JCM | Free Full-Text | An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis
